What's breaking now, across thousands of outlets.
Eli Lilly and Novo are developing new amylin drugs that serve as another biological lever to pull in treating obesity and diabetes.
We haven't written up this one. CNBC World has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
Falls kill thousands of older Americans each year. One expert argues the U.S. needs clearer, more consistent floor testing.
Eli Lilly is looking to get into the aesthetics business and acquire drugs that could treat skin aging and diseases, body shape and hair conditions, according to a new job posting. The
(MedPage Today) -- Hypofractionated postmastectomy radiotherapy continued to provide locoregional control for patients with high-risk breast cancer, 10-year data from a phase III trial showed.
Mumbai: The Maharashtra Food and Drug Administration (FDA) has cancelled the wholesale drug licences of Cipla Pharma & Life Sciences Ltd’s warehouse at Wadki in Pune, citing misbranding of a medicine…
Continued improvement: An increased response was seen in participants on litifilimab from week 24 through week 52, with more individuals achieving clear or almost clear skin (27.2%; CLA IGA 0-1) and…
(MedPage Today) -- The following is a transcript of the podcast episode: Rachael Robertson: Hey everybody! Welcome to MedPod Today, the podcast series where MedPage Today reporters share deeper…
